Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Unknown 3Terminated 1Completed 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 2Neutropenia 1Central Line-associated Bloodstream Infection (CLABSI) 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × OTHER × Vascular Access Devices × Clear all
NCT05740150 2023-02-22

CATERPILLAR

Princess Maxima Center for Pediatric Oncology

Phase NA Unknown
462 enrolled

Central Line-associated Bloodstream Infection (CLABSI)

NCT04103021 2019-09-25

Ultrasound Guided Port-A-Cath Isertion in Cancer Patients

Assiut University

Phase NA Unknown
20 enrolled
Tumor-Agnostic

Neoplasms

NCT02967341 2016-11-18

Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer Patients

Universitair Ziekenhuis Brussel

Phase 4 Unknown
15 enrolled

Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡